STOCK TITAN
  1. Home
  2. Sec-filings
  3. BIAFW
  4. [EFFECT] bioAffinity Technologies, Inc. Warrant SEC Filing

[EFFECT] bioAffinity Technologies, Inc. Warrant SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 3, 2025
Accession Number: 0001641172-25-016923
Submission Type: POS AM
CIK: 0001712762
Company Name: bioAffinity Technologies, Inc.
File Number: 333-264463

Source: View Original Filing on SEC EDGAR

Stock BIAFW logo
bioAffinity Tech

NASDAQ:BIAFW

BIAFW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

BIAFW Latest News

Feb 19, 2026
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
Feb 17, 2026
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study
Feb 9, 2026
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board
Jan 7, 2026
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
Dec 3, 2025
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable

BIAFW Latest SEC Filings

Feb 19, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event
Feb 19, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event
Feb 17, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event
Feb 17, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event
Feb 10, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event

BIAFW Stock Data

1.60M
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
SAN ANTONIO